Factors associated with impairment of quadriceps muscle function in Chinese patients with chronic obstructive pulmonary disease

Chunrong Ju, Rongchang Chen, Chunrong Ju, Rongchang Chen

Abstract

Background: Quadriceps muscle dysfunction is well confirmed in chronic obstructive pulmonary disease (COPD) and reported to be related to a higher risk of mortality. Factors contributing to quadriceps dysfunction have been postulated, while not one alone could fully explain it and there are few reports on it in China. This study was aimed to investigate the severity of quadriceps dysfunction in patients with COPD, and to compare quadriceps muscle function in COPD and the healthy elderly.

Methods: Quadriceps strength and endurance capabilities were investigated in 71 COPD patients and 60 age-matched controls; predicted values for quadriceps strength and endurance were calculated using regression equations (incorporating age, gender, anthropometric measurements and physical activities), based on the data from controls. Potential parameters related to quadriceps dysfunction in COPD were identified by stepwise regression analysis.

Results: Mean values of quadriceps strength was 46% and endurance was 38% lower, in patients with COPD relative to controls. Gender, physical activities and anthropometric measurements were predictors to quadriceps function in the controls. While in COPD, forced expiratory volume in 1 second percentage of predicted value (FEV1% pred), nutritional depletion, gender and physical inactivity were identified as independent factors to quadriceps strength (R(2) = 0.72); FEV1%pred, thigh muscle mass, serum levels of tumor necrosis factor-alpha (TNF-α) and gender were correlated to quadriceps endurance variance, with each p<0.05.

Conclusion: Quadriceps strength and endurance capabilities are both substantially impaired in Chinese COPD patients, with strength most affected. For the controls, physical activity is most important for quadriceps function. While for COPD patients, quadriceps dysfunction is related to multiple factors, with airflow limitation, malnutrition and muscle disuse being the main ones.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. The functional test of quadriceps.
Figure 1. The functional test of quadriceps.
Figure 2. Simultaneous force and surface electromyography…
Figure 2. Simultaneous force and surface electromyography (SEMG) recordings during quadriceps maximal volitional contraction (QMVC) tests: the lines on the top channel represent the 3 consecutive volitional contraction forces; SEMG signals from vastus lateralis muscle (VL-M), rectus femoris muscle (RF-M) and vastus medialis muscle (VM-M) were shown in channel 2, 3 and 4, respectively; the number below the X axis represents the time (minute: second).
QMVC was about 25(Figure 2A) 40 kg in a male normal subject (Figure 2B).
Figure 3. Quadriceps endurance time test: the…
Figure 3. Quadriceps endurance time test: the lines on the top channel represent the sustained isometric contraction at 60% value of quadriceps maximal volitional contraction (QMVC); surface electromyography (SEMG) from vastus lateralis muscle (VL-M), rectus femoris muscle (RF-M) and vastus medialis muscle (VM-M) were shown below the force line; the number below the X axis was the time (minutes: seconds).
The time to fatigue (QTf) in this figure was about 2 minutes and 20 seconds (140 seconds).

References

    1. Butcher SJ, Meske JM, Sheppard MS (2004) Reductions in functional balance, coordination, and mobility measures among patients with stable chronic obstructive pulmonary disease. J Cardiopulmonary Rehabil 24: 274–280.
    1. Caron MA, Debigaré R, Dekhuijzen PN, Maltais F (2009) Comparative assessment of the quadriceps and the diaphragm in patients with COPD. J Appl Physiol 107: 952–61.
    1. Donaldson AV, Maddocks M, Martolini D, Polkey MI, Man WD (2012) Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis 7: 523–535.
    1. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82: 53–59.
    1. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, et al. (2000) Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55: 848–853.
    1. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, et al. (2007) Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62: 115–120.
    1. Rabinovich RA, Vilaró J (2010) Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 16: 123–133.
    1. Ju CR, Chen RC (2011) Quadriceps strength assessed by magnetic stimulation of femoral nerve in patients with chronic obstructive pulmonary disease. Chin Med J (Engl) 124: 2309–2315.
    1. Asia Pacific CRG (2005) Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology 10: 9–17.
    1. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, et al. (2007) A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 8: 25.
    1. Vivodtzev I, Pepin JL, Vottero G, Mayer V, Porsin B, et al. (2006) Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest 129: 1540–1548.
    1. Laaban JP, Kouchakji B, Dore MF, Orvoen-Frija E, David P, et al. (1993) Nutritional status of patients with chronic obstructive pulmonary disease and acute respiratory failure. Chest 103: 1362–1368.
    1. Lee RC, Wang Z, Heo M, Ross R, Janssen I, et al. (2000) Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr 72: 796–803.
    1. Baecke JA, Burema J, Frijters JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36: 936–942.
    1. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA (1991) A physical activity questionnaire for the elderly. Med Sci Sports Exerc 23: 974–979.
    1. Miller AE, MacDougall JD, Tarnopolsky MA, Sale DG (1993) Gender differences in strength and muscle fiber characteristics. Eur J Appl Physiol Occup Physiol 66: 254–262.
    1. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, et al. (2010) The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 36: 81–88.
    1. Zattara-Hartmann MC, Badier M, Guillot C, Tomei C, Jammes Y (1995) Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve 18: 495–502.
    1. Van't Hul A, Harlaar J, Gosselink R, Hollander P, Postmus P, et al. (2004) Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease. Muscle Nerve 29: 267–274.
    1. Serres I, Gautier V, Varray A, Prefaut C (1998) Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 113: 900–905.
    1. Coronell C, Orozco-Levi M, Mendez R, Ramirez-Sarmiento A, Galdiz JB, et al. (2004) Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 24: 129–136.
    1. Gosker HR, Kubat B, Schaart G, van der Vusse GJ, Wouters EF, et al. (2003) Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J 22: 280–5.
    1. Degens H, Sanchez Horneros JM, Heijdra YF, Dekhuijzen PN, Hopman MT (2005) Skeletal muscle contractility is preserved in COPD patients with normal fat-free mass. Acta Physiol Scand 184: 235–42.
    1. Gosker HR, Lencer NH, Franssen FM, van der Vusse GJ, Wouters EF, et al. (2003) Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 123: 1416–24.
    1. Dempsey JA, Romer L, Rodman J, Miller J, Smith C (2006) Consequences of exercise-induced respiratory muscle work. Respir Physiol Neurobiol 151: 242–250.
    1. Gosker HR, Zeegers MP, Wouters EF, Schols AM (2007) Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62: 944–949.
    1. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM (2007) Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 30: 73–79.
    1. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, et al. (1998) Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 30: 1467–1474.
    1. Di Carlo A, De Mori R, Martelli F, Pompilio G, Capogrossi MC, et al. (2004) Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. J Biol Chem 279: 16332–8.
    1. Engelen MP, Schols AM, Does JD, Wouters EF (2000) Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 71: 733–738.
    1. Sugawara K, Takahashi H, Kasai C, Kiyokawa N, Watanabe T, et al. (2010) Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD. Respir Med 104: 1883–1889.
    1. Ju CR, Chen RC (2012) Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease. Respir Med 106: 102–108.
    1. Kobayashi A, Yoneda T, Yoshikawa M, Ikuno M, Takenaka H, et al. (2000) The relation of fat-free mass to maximum exercise performance in patients with chronic obstructive pulmonary disease. Lung 178: 119–127.
    1. Edwards RH, Young A, Hosking GP, Jones DA (1977) Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 52: 283–290.
    1. Sandland CJ, Singh SJ, Curcio A, Jones PM, Morgan MD (2005) A profile of daily activity in chronic obstructive pulmonary disease. J Cardiopulm Rehabil 25: 181–183.
    1. Hernandes NA, Teixeira Dde C, Probst VS, Brunetto AF, Ramos EM, et al. (2009) Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J Bras Pneumol 35: 949–956.
    1. O'Shea SD, Taylor NF, Paratz JD (2009) Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review. Chest 136: 1269–1283.
    1. Reid MB, Li YP (2001) Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2: 269–272.
    1. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, et al. (2008) Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63: 100–107.
    1. Warwick G, Thomas PS, Yates DH (2013) Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology 18: 874–884.
    1. Hacievliyagil SS, Mutlu LC, Temel I (2013) Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers. Niger J Clin Pract 16: 76–81.
    1. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61: 17–22.

Source: PubMed

3
Sottoscrivi